Cargando…
Safety, Tolerability, and Pharmacokinetics of Multiple Repeated Oral Doses of the α2/3/5‐Subtype Selective GABA(A)‐Positive Allosteric Modulator PF‐06372865 in Healthy Volunteers
Multiple‐dose pharmacokinetics (PK) and safety were investigated in this phase 1 study of PF‐06372865, a positive allosteric modulator of α2/3/5 subunit‐containing γ‐aminobutyric acid A receptors (NCT03351751). In 2 cohorts (7‐8 PF‐06372865 and 2 placebo in each cohort), healthy adult subjects recei...
Autores principales: | Gurrell, Rachel, Whitlock, Mark, Wei, Hua, Shen, Zhongzhou, Ogden, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359322/ https://www.ncbi.nlm.nih.gov/pubmed/33465277 http://dx.doi.org/10.1002/cpdd.912 |
Ejemplares similares
-
Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers
por: Naik, Himanshu, et al.
Publicado: (2020) -
Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics
por: Li, Junfeng, et al.
Publicado: (2015) -
Pronounced antiseizure activity of the subtype‐selective GABA(A)
positive allosteric modulator darigabat in a mouse model of drug‐resistant focal epilepsy
por: Gurrell, Rachel, et al.
Publicado: (2022) -
Understanding subtype-selective allosteric modulation of GABA(A) receptors
por: Puthenkalam, Roshan, et al.
Publicado: (2012) -
Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers
por: Orrell, Catherine, et al.
Publicado: (2008)